Dimethyl aminoterephthalate
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
5372-81-6COC(=O)c1ccc(C(=O)OC)c(N)c1DSSKDXUDARIMTR-UHFFFAOYSA-N5372-81-6DTXSID5022225CHEMBL1336047Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 0.6% (1 of 174) of reports.
Warning
H315 (35.1%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 174 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 07-12-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/10651
1,4-Benzenedicarboxylic acid, 2-amino-, dimethyl ester: Does not have an individual approval but may be used under an appropriate group standard
VerwendenDimethyl aminoterephthalate is used in the preparation of imidazotetrazinones as probes for the action of temozolomide. It is also used to prepare aminoquinazolines with neurokinin-2 receptor antagonist activity.
Wird geladen…